ADVANZ PHARMA Corp. Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 128.744 million compared to USD 119.644 million a year ago. Operating loss was USD 5.405 million compared to USD 111.810 million a year ago. Net loss was USD 42.025 million compared to USD 119.175 million a year ago. Basic loss per share from continuing operations was USD 0.86 compared to USD 2.44 a year ago. For the nine months, sales was USD 390.602 million compared to USD 386.359 million a year ago. Operating income was USD 850,000 compared to operating loss of USD 114.413 million a year ago. Net loss was USD 77.306 million compared to USD 171.418 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 3.5 a year ago.